A vitamin K epoxide reductase complex subunit-1 (VKORC1) mutation in a patient with vitamin K antagonist resistance

被引：47
|
作者：
Bodin, L
Horellou, MH
Flaujac, C
Loriot, MA
Samama, MM
机构：
[1] Hop Hotel Dieu, Dept Biol Hematol, F-75181 Paris, France
[2] Univ Paris 05, INSERM, URMS 490, Paris, France
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2005年 / 3卷 / 07期
关键词：
resistance; vitamin K epoxide reductase; vitamin K antagonist;
D O I：
10.1111/j.1538-7836.2005.01449.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1533 / 1535
页数：3
相关论文
共 50 条
  • [31] Intrauterine subdural hemorrhage associated with profound deficiency of the vitamin K dependent clotting factors in an infant homozygous for a common polymorphism in the vitamin K epoxide reductase complex 1 (VKORC1) promoter
    Schwartz, Nadav
    Oldenburg, Johannes
    Hart, David
    Nardi, Michael
    Most, Ori Langer
    Bonanno, Clarissa
    Timor-Tritsch, Ilan T.
    Karpatkin, Margaret
    BLOOD, 2007, 110 (11) : 640A - 641A
  • [32] Speculations on vitamin K, VKORC1 genotype and autism
    DeSoto, M. C.
    MEDICAL HYPOTHESES, 2016, 96 : 30 - 33
  • [33] Regulatory polymorphism in vitamin K epoxide reductase complex subunit 1 (VKORC1) affects gene expression and warfarin dose requirement (vol 112, pg 1013, 2008)
    Wang, D. X.
    BLOOD, 2009, 113 (06) : 1393 - 1394
  • [34] Multiple genetic alterations in vitamin K epoxide reductase complex subunit 1 gene (VKORC1) can explain the high dose requirement during oral anticoagulation in humans
    Bodin, L.
    Perdu, J.
    Diry, M.
    Horellou, M. -H.
    Loriot, M. -A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2008, 6 (08) : 1436 - 1439
  • [35] Association between Vitamin K Epoxide Reductase (VKORC1)-1639G>A Polymorphism and Osteoporosis in Postmenopausal Women
    Kutluturk, Faruk
    Inanir, Ahmet
    Rustemoglu, Aydin
    Kaya, Suheyla U.
    Demir, Ayse K.
    Dursun, Gul
    Yigit, Serbulent
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2018, 18 (03) : 281 - 286
  • [36] Vitamin K epoxide reductase (VKORC1) genetic polymorphism is associated to venous thromboembolism: results from the EDITH study
    Lacut, K.
    Larramendy-Gozalo, C.
    Duchemin, J.
    Mercier, B.
    Gourhant, L.
    Mottier, D.
    Becquemont, L.
    Oger, E.
    Verstuyft, C.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2007, 21 : 71 - 71
  • [37] Determination of the warfarin inhibition constant Ki for vitamin K 2,3-epoxide reductase complex subunit-1 (VKORC1) using an in vitro DTT-driven assay (vol 1830, pg 4202, 2013)
    Bevans, Carville G.
    Krettler, Christoph
    Reinhart, Christoph
    Tran, Helene
    Kossmann, Katja
    Watzka, Matthias
    Oldenburg, Johannes
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2014, 1840 (07): : 2382 - 2384
  • [38] Regulation of Osteocalcin Endocrine Functions By the Vitamin K Epoxide Reductases 1 and 1/1 (Vkorc1 and Vkorc1l1)
    Ferron, Mathieu
    Karsenty, Gerard
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [39] Lack of Association Between Type 2 Diabetes and the 3673G/A and 9041G/A Gene Variants of Vitamin K Epoxide Reductase Complex Subunit 1 (VKORC1)
    Ozbayer, Cansu
    Kurt, HUlyam
    Kebapci, Medine Nur
    Cosan, Didem Turgut
    Colak, Ertugrul
    Gunes, Hasan Veysi
    Degirmenci, Irfan
    INTERNATIONAL JOURNAL FOR VITAMIN AND NUTRITION RESEARCH, 2016, 86 (3-4) : 133 - 139
  • [40] Human Vitamin K 2,3-Epoxide Reductase Complex Subunit 1-like 1 (VKORC1L1) Mediates Vitamin K-dependent Intracellular Antioxidant Function
    Westhofen, Philipp
    Watzka, Matthias
    Marinova, Milka
    Hass, Moritz
    Kirfel, Gregor
    Mueller, Jens
    Bevans, Carville G.
    Mueller, Clemens R.
    Oldenburg, Johannes
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (17) : 15085 - 15094
12345